Polyganics wins FDA 510(k) clearance for Neurocap

by Fink Densford for MassDevice.com

Polyganics said today it won FDA 510(k) clearance for its Neurocap device, designed to reduce neuroma formation and facilitate tissue repair.

Neuromas, also known as pinched nerves or nerve tumors, are benign growths of nerve tissue that can cause pain, burning sensation, tingling or numbness, according to the company.

“Neuroma-induced neuropathic pain and morbidity can seriously affect the quality of a patient’s daily life. Neurocap, a transparent tubular device with a sealed end, is the first and only synthetic nerve capping device cleared for the management of symptomatic neuromas. Current approaches are based on surgical removal of the neuroma and surrounding scar tissue, then placing the nerve stump in tissue subjected to minimal mechanical stimulation. However, these approaches have in many cases unsatisfactory outcomes. With our bioresorbable medical device Neurocap we offer orthopedic and hand surgeons a valuable new tool that contributes to the clinical management of neuromas and that can improve the daily life of patients. Receiving U.S. FDA 510(k) clearance for Neurocap is another major milestone for Polyganics,” CEO Rudy Mareel said in prepared remarks.

Last week, Polyganics said it signed an exclusive distribution deal with strategic partner MicroAire Surgical Instruments that will put it in charge of distributing Polyganics peripheral nerve repair portfolio in the U.S., Canada and Puerto Rico.

The company sold its ear, nose and throat business to Stryker (NYSE:SYK) in 2014.

See the full article here.

Save time with kBLASTER's unique result management features of sorting, My Favorites, Saved Search and Search History from a web browser, so either mobile devices or computers can be used to quickly find your primary predicate, multiple predicates or reference devices to build a successful 510(k) clearance strategy. Save money in your 510(k) regulatory strategy and follow-on 510(k) submission spend by enabling self-service extraction of actionable insight from nearly 63,000 FDA medical device 510(k) clearance summaries, plus more than 76,000 splash pages for a total more than 139,000 records.